KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Equity (2021 - 2025)

Ginkgo Bioworks Holdings filings provide 5 years of Return on Equity readings, the most recent being 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Ginkgo Bioworks Holdings, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2021 to a low of 0.02% in Q3 2022.
  • Median Return on Equity over the past 5 years was 0.01% (2023), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Equity: decreased -2bps in 2022 and later rose 2bps in 2023.
  • Ginkgo Bioworks Holdings' Return on Equity stood at 0.01% in 2021, then dropped by -15bps to 0.01% in 2022, then skyrocketed by 43bps to 0.01% in 2023, then rose by 5bps to 0.01% in 2024, then rose by 19bps to 0.01% in 2025.
  • The last three reported values for Return on Equity were 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.